DM
Insider
Duncan McKechnie
EVP, Chief Commercial OfficerDuncan McKechnie (EVP, Chief Commercial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $2.4M of VRTX (4,910 sh across 2 lots, as filed), executed Feb 25.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.7M
shares × price, as filed
Last traded
Jul 2
Filed Jul 7
Median ADV $756.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
VRTX
Vertex Pharmaceuticals Incorporated
VRTX · 0 buys · 4 sells
4 filings
Recent filings
VRTXSALE
Vertex Pharmaceuticals Incorporated
View filing →
$800K1,541 sh × $519.00
Exec Jul 2
Filed Jul 7 · 4:08 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $1.3M
2,633 sh × $498.42
Exec Mar 11
Filed Mar 13 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $1.2M
2,437 sh × $475.30
Exec Mar 4
Filed Mar 6 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $2.4M
4,910 sh across 2 lots
Exec Feb 25
Filed Feb 26 · 5:30 PM ET